Revvity
China Instrument Sales Drag on Revvity Life Science Segment as Company Q3 Revenues Rise 2 Percent
Premium
Similar to other firms, the firm said that it has been negatively impacted as customers in China wait for government stimulus funding to arrive.
BARDA Awards Revvity $9.2M, Partners With Sherlock Biosciences for COVID/Flu Home Tests
Both firms will develop rapid, home-use diagnostic tests to simultaneously detect SARS-CoV-2, influenza A, and influenza B.
In Brief This Week: Mainz Biomed, Evotec, Hologic, Proteomics International, PacBio, More
News items for the week of Oct. 21, 2024.
Barclays Upgrades Revvity to Overweight
The firm's analysts wrote that they see stability in Revvity's diagnostics business and growth above peers in its life sciences and reagents business.
Revvity Gets CE Mark for PCR Test Used to Guide Alzheimer's Therapy
Revvity's Euroimmun subsidiary has launched the EuroRealTime APOE assay in Europe for the detection and differentiation of common forms of the APOE gene.
Sep 18, 2024
Apr 1, 2024
Feb 1, 2024
Revvity Q4 Non-COVID Revenues Decline 3 Percent
Dec 22, 2023
Wells Fargo Initiates Coverage of Revvity
Dec 4, 2023